Our Impact at a Glance
What we achieved in 2022-2023:
200+
Portfolio trials supported
3900+
Patients recruited to portfolio trials
71+
Percent increase in patients above the pre-3CTN baseline
Stay Connected
News
Canada needs a national system for cancer clinical trials
Toronto Star –
Clinical trials are the most effective means of ensu…
3CTN’s Executive Director talks CRAFT DCT model development
Stephen Sundquist joins the Decentralized: The Decentralized Trials an…